论文信息 - A nucleoside-sparing regimen of dolutegravir plus ritonavir-boosted atazanavir in HIV-1-infected patients with virological failure: the DOLATAV study - 字舞流文

A nucleoside-sparing regimen of dolutegravir plus ritonavir-boosted atazanavir in HIV-1-infected patients with virological failure: the DOLATAV study

A. Lazzarin | L. Galli | M. Locatelli | A. Castagna | S. Nozza | N. Gianotti | A. Bigoloni | V. Spagnuolo | L. Fumagalli | A. Poli | Davide Ferrari